|
|
 |
 |
 |
 |
 |
 |
 |
|
GSH/Nickel/Cobalt Materials - Glutathione ChroMatrix™ |
|
 |
 |
 |
 |
 |
 |

6% CL-Glutathione ChroMatrix™ is a superior, 6% cross-linked agarose support with covalently coupled glutathione attached via a 12-atom spacer. 6% CL-Glutathione ChroMatrix™ facilitates the purification of some native Glutathione S Transferase (GST) enzymes and recombinant GST-tagged proteins. It can be used in gravity-flow columns, FPLC and small- or large-scale batches. The material can be reused several times without any significant decrease in yield.
|

Features:
- High Binding capacity > 20 mg of protein/ml of ChroMatrix™ resin
- Fast flow rate
- Suitable for GST pull down experiments
|
 |
|
SDS-PAGE analysis of the purification of recombinant human biliverdin-IX reductase
|

| lane 1: | molecular mass markers (sizes indicated) | | lane 2: | lysate from cells transformed with control vector (pGEX-KG with no insert) | | lane 3: | lysate from cells transformed with pGEX-BVR-A (with isopropyl-1-thio--D-galactopyranoside) | | lane 4: | lysate from cells transformed with pGEX-BVR-A (without isopropyl-1-thio--D-galactopyranoside) | | lane 5: | purified GST-BVR-A (5 µg) | | lane 6: | cleaved BVR-A (5 µg) |
|
|
|
 |
 |  |
| 6% CL-Glutathione ChroMatrix™ | |  |
 |  |
 |
 |
 |
Product |
 |
 |
 |
Cat. No. |
 |
 |
 |
Amount |
 |
 |
 |
Price (EUR) |
 |
 |
 |
Buy |
 |
 |
 |
|
 |
 |
 |
Bulk material - 10 ml |
 |
 |
 |
AC-201-10 |
 |
 |
 |
10 ml |
 |
 |
 |
140,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Bulk material - 50 ml |
 |
 |
 |
AC-201-50 |
 |
 |
 |
50 ml |
 |
 |
 |
650,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Bulk material - 100 ml |
 |
 |
 |
AC-201-100 |
 |
 |
 |
100 ml |
 |
 |
 |
1.300,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Bulk material - 500 ml |
 |
 |
 |
AC-201-500 |
 |
 |
 |
500 ml |
 |
 |
 |
5.000,00 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |  | |  | |  |  |
|